Compare JQC & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JQC | PFE |
|---|---|---|
| Founded | 2003 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 753.9M | 145.4B |
| IPO Year | N/A | N/A |
| Metric | JQC | PFE |
|---|---|---|
| Price | $5.04 | $25.79 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $27.90 |
| AVG Volume (30 Days) | 714.6K | ★ 51.9M |
| Earning Date | 01-01-0001 | 11-04-2025 |
| Dividend Yield | ★ 11.13% | 6.65% |
| EPS Growth | N/A | ★ 131.89 |
| EPS | N/A | ★ 1.73 |
| Revenue | N/A | ★ $62,785,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.97 |
| Revenue Growth | N/A | ★ 3.89 |
| 52 Week Low | $4.82 | $20.92 |
| 52 Week High | $5.65 | $27.69 |
| Indicator | JQC | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 44.52 | 56.25 |
| Support Level | $5.00 | $25.13 |
| Resistance Level | $5.08 | $26.19 |
| Average True Range (ATR) | 0.05 | 0.47 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 45.93 | 69.13 |
Nuveen Credit Strategies Income Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. The fund meets its investment objectives by investing its managed assets in senior secured and second lien loans, and its managed assets across the capital structure of companies (including equity securities) with a primary emphasis on high yield bonds, convertible securities and other forms of income-producing securities.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.